Clinical trial
Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
NCT00335933 · Depomed, Industry · Completed
Key facts
| NCT number | NCT00335933 |
|---|---|
| Title | Safety and Efficacy of Gabapentin in Postherpetic Neuralgia |
| Official title | A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Postherpetic Neuralgia |
| Lead sponsor | Depomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | Gabapentin extended-release tablets |
| Enrollment | 378 |
| Start date | May 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jun 12, 2006 |
| Last update posted | Aug 2, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: